Tuesday, 19. November 2013 13:03 | Author:Anett Albrecht
by Matt Windsor: During the past two weeks, the fifth international symposium between Leipzig and Vanderbilt universities was held on the Vanderbilt campus, as seven Leipzig faculty members presented a series of chemical biology-related lectures. The symposium offered an opportunity to highlight the ongoing success of the international collaboration. To date, there have been 17 joint publications between research groups at the two universities.
This summer, the first federally funded research grant resulting from the collaboration was awarded by the National Institutes of Health (NIH). The project is aimed at developing drugs for a specific type of protein known as a G protein-coupled receptor (GPCR). The grant was spearheaded by Annette Beck-Sickinger, Ph.D., professor of Biochemistry and Bioorganic Chemistry at Leipzig, and at Vanderbilt by Jens Meiler, Ph.D., associate professor of Chemistry and Pharmacology, and David Weaver, Ph.D., assistant professor of Pharmacology and scientific director of the Vanderbilt High Throughput Screening Facility.
“We work on GPCRs that play a role in obesity and colon cancer,” Beck-Sickinger said. “We know these receptors. In Leipzig, we have set up biochemical assays that are necessary to study these receptors, a process that required several years of dedicated effort.”